Clearside Biomedical, Inc. (CLSD) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1152417,
    "name": "Clearside Biomedical, Inc.",
    "stock_name": "Clearside Biomedical, Inc.",
    "full_name": "Clearside Biomedical, Inc.",
    "name_url": "stocks-analysis/clearside-biomedical-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "0.90",
    "chg": 0.07,
    "chgp": "9.08%",
    "dir": 1,
    "prev_price": "0.83",
    "mcapval": "26.39",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2305,
    "indexname": "S&P 500",
    "isin": "US1850631045",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "548.15 k",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/clearside-biomedical-inc-1152417-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Clearside Biomedical Forms Golden Cross, Signaling Potential Bullish Breakout",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/clearside-biomedical-forms-golden-cross-signaling-potential-bullish-breakout-3565412",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/9/ClearsideBiomed_goldencross_3565412.png",
        "date": "2025-09-24 14:18:58",
        "description": "Clearside Biomedical, Inc. has recently achieved a Golden Cross, indicating a potential shift in momentum. While daily moving averages and MACD suggest positive short-term strength, the RSI indicates possible overbought conditions. Despite a recent decline, the stock has shown remarkable long-term growth, significantly outperforming the S&P 500."
      },
      {
        "title": "Clearside Biomedical Hits New 52-Week High, Surging 230% in a Year",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/clearside-biomedical-hits-new-52-week-high-surging-230-in-a-year-3565343",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/9/ClearsideBiomed_priceRelatedfactors_3565343.png",
        "date": "2025-09-24 13:36:42",
        "description": "Clearside Biomedical, Inc. has achieved a new 52-week high, reflecting a significant increase over the past year and outperforming the S&P 500. With a market cap of USD 26 million, the company demonstrates effective management of shareholder equity, despite its loss-making status and complex valuation metrics."
      },
      {
        "title": "Clearside Biomedical Hits New 52-Week High of $4.52, Up 265.83%",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/clearside-biomedical-hits-new-52-week-high-of-452-up-26583-3559375",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/9/ClearsideBiomed_priceRelatedfactors_3559375.png",
        "date": "2025-09-23 15:45:28",
        "description": "Clearside Biomedical, Inc. has achieved a new 52-week high, reflecting a substantial increase over the past year and significantly outperforming the S&P 500. With a market cap of USD 26 million, the company demonstrates effective management through a high return on equity and a strong balance sheet."
      },
      {
        "title": "Is Clearside Biomedical, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-clearside-biomedical-inc-technically-bullish-or-bearish-3547353",
        "imagepath": "",
        "date": "2025-09-20 19:53:29",
        "description": "As of 18 August 2025, the technical trend for Clearside Biomedical, Inc. has changed from mildly bearish to bearish. The current stance is bearish with weak strength indicated by the daily moving averages being mildly bearish and the weekly RSI being bearish. Although the MACD and Bollinger Bands are bullish on both weekly and monthly time frames, the overall bearish trend is reinforced by the bearish RSI readings. The stock has significantly outperformed the S&P 500 over the past week and month, but longer-term returns show underperformance, particularly over the 3-year and 5-year periods...."
      },
      {
        "title": "Is Clearside Biomedical, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-clearside-biomedical-inc-overvalued-or-undervalued-3543750",
        "imagepath": "",
        "date": "2025-09-20 18:27:40",
        "description": "As of 14 August 2023, the valuation grade for Clearside Biomedical, Inc. has moved from does not qualify to risky. The company is considered overvalued based on its negative valuation ratios, including a Price to Book Value of -1.33, an EV to EBIT of -3.91, and an EV to EBITDA of -3.96. In comparison to peers, Kinnate Biopharma, Inc. has a fair valuation with a P/E of -1.1313, while Veru, Inc. is also rated risky with an EV to EBITDA of -1.1714.\n\nDespite the recent surge in stock price, with a 1-week return of 1012.70% compared to the S&P 500's 1.05%, the overall financial metrics indicate that Clearside Biomedical, Inc. is not positioned favorably within its industry. The combination of negative ratios and a risky valuation grade suggests that investors should approach this stock with caution...."
      },
      {
        "title": "Clearside Biomedical Hits New 52-Week High of $4.43, Up 229%",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/clearside-biomedical-hits-new-52-week-high-of-443-up-229-3519628",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/9/ClearsideBiomed_priceRelatedfactors_3519628.png",
        "date": "2025-09-16 11:29:22",
        "description": "Clearside Biomedical, Inc. has achieved a new 52-week high, reflecting a substantial one-year stock performance increase. With a market capitalization of USD 26 million, the company shows a strong return on equity despite being loss-making. Its unique financial structure includes a negative debt-to-equity ratio and price-to-book ratio."
      }
    ],
    "total": 12,
    "sid": "1152417",
    "stock_news_url": "https://www.marketsmojo.com/news/clearside-biomedical-inc-1152417"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Clearside Biomedical Forms Golden Cross, Signaling Potential Bullish Breakout

2025-09-24 14:18:58

Clearside Biomedical, Inc. has recently achieved a Golden Cross, indicating a potential shift in momentum. While daily moving averages and MACD suggest positive short-term strength, the RSI indicates possible overbought conditions. Despite a recent decline, the stock has shown remarkable long-term growth, significantly outperforming the S&P 500.

Clearside Biomedical Hits New 52-Week High, Surging 230% in a Year

2025-09-24 13:36:42

Clearside Biomedical, Inc. has achieved a new 52-week high, reflecting a significant increase over the past year and outperforming the S&P 500. With a market cap of USD 26 million, the company demonstrates effective management of shareholder equity, despite its loss-making status and complex valuation metrics.

Clearside Biomedical Hits New 52-Week High of $4.52, Up 265.83%

2025-09-23 15:45:28

Clearside Biomedical, Inc. has achieved a new 52-week high, reflecting a substantial increase over the past year and significantly outperforming the S&P 500. With a market cap of USD 26 million, the company demonstrates effective management through a high return on equity and a strong balance sheet.

Is Clearside Biomedical, Inc. technically bullish or bearish?

2025-09-20 19:53:29

As of 18 August 2025, the technical trend for Clearside Biomedical, Inc. has changed from mildly bearish to bearish. The current stance is bearish with weak strength indicated by the daily moving averages being mildly bearish and the weekly RSI being bearish. Although the MACD and Bollinger Bands are bullish on both weekly and monthly time frames, the overall bearish trend is reinforced by the bearish RSI readings. The stock has significantly outperformed the S&P 500 over the past week and month, but longer-term returns show underperformance, particularly over the 3-year and 5-year periods....

Is Clearside Biomedical, Inc. overvalued or undervalued?

2025-09-20 18:27:40

As of 14 August 2023, the valuation grade for Clearside Biomedical, Inc. has moved from does not qualify to risky. The company is considered overvalued based on its negative valuation ratios, including a Price to Book Value of -1.33, an EV to EBIT of -3.91, and an EV to EBITDA of -3.96. In comparison to peers, Kinnate Biopharma, Inc. has a fair valuation with a P/E of -1.1313, while Veru, Inc. is also rated risky with an EV to EBITDA of -1.1714. Despite the recent surge in stock price, with a 1-week return of 1012.70% compared to the S&P 500's 1.05%, the overall financial metrics indicate that Clearside Biomedical, Inc. is not positioned favorably within its industry. The combination of negative ratios and a risky valuation grade suggests that investors should approach this stock with caution....

Clearside Biomedical Hits New 52-Week High of $4.43, Up 229%

2025-09-16 11:29:22

Clearside Biomedical, Inc. has achieved a new 52-week high, reflecting a substantial one-year stock performance increase. With a market capitalization of USD 26 million, the company shows a strong return on equity despite being loss-making. Its unique financial structure includes a negative debt-to-equity ratio and price-to-book ratio.

View All News